Nuclear Medicine & Radiation Therapy

Department of Pharmaceutics, Kakatiya University, India

Publications

• Short Communication   
  A Short note on Pancreatic Neuroendocrine Tumors
  Author(s): Madipalli Karthik*
  
  Pancreatic neuroendocrine neoplasms (PanNENs) are uncommon tumors, representing 2�??5% of pancreatic malignancies and 6�??7% of all NENs, with an expected yearly rate of 0.48 per 100,000 people [1,2,3,4]. The middle age at determination is 60 years, with a slight power of female sex. The quantity of patients with recently analyzed PanNENs is expanding (overwhelmingly non-practical tumors), basically because of expanded mindfulness and improved analytic strategies. Pancreatic neuroendocrine neoplasms show a more limited generally speaking endurance (OS) when contrasted with other gastro-entero-pancreatic (GEP)- NENs, with five-year OS of 38% as indicated by the Surveillance, Epidemiology, and End Results (SEER) library, however a more hopeful result has been accounted for in a few European examinations... Read More»
  DOI: 10.37421/2155-9619.2021.12.417

  Abstract HTML PDF